George Warimwe
George Warimwe
Verified email at
Cited by
Cited by
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ...
The Lancet 397 (10269), 99-111, 2021
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four …
M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ...
The Lancet 397 (10277), 881-891, 2021
Seroprevalence of anti–SARS-CoV-2 IgG antibodies in Kenyan blood donors
S Uyoga, IMO Adetifa, HK Karanja, J Nyagwange, J Tuju, P Wanjiku, ...
Science 371 (6524), 79-82, 2021
Targets of antibodies against Plasmodium falciparum–infected erythrocytes in malaria immunity
JA Chan, KB Howell, L Reiling, R Ataide, CL Mackintosh, FJI Fowkes, ...
The Journal of clinical investigation 122 (9), 3227-3238, 2012
ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice
NK Alharbi, E Padron-Regalado, CP Thompson, A Kupke, D Wells, ...
Vaccine 35 (30), 3780-3788, 2017
Plasmodium falciparum var gene expression is modified by host immunity
GM Warimwe, TM Keane, G Fegan, JN Musyoki, CRJC Newton, A Pain, ...
Proceedings of the National Academy of Sciences 106 (51), 21801-21806, 2009
Analysis of immunity to febrile malaria in children that distinguishes immunity from lack of exposure
P Bejon, G Warimwe, CL Mackintosh, MJ Mackinnon, SM Kinyanjui, ...
Infection and immunity 77 (5), 1917-1923, 2009
Ratio of monocytes to lymphocytes in peripheral blood identifies adults at risk of incident tuberculosis among HIV-infected adults initiating antiretroviral therapy
V Naranbhai, AVS Hill, SS Abdool Karim, K Naidoo, Q Abdool Karim, ...
The Journal of infectious diseases 209 (4), 500-509, 2014
Rift Valley fever: biology and epidemiology
D Wright, J Kortekaas, TA Bowden, GM Warimwe
Journal of General Virology 100 (8), 1187-1199, 2019
Chimpanzee adenovirus vaccine provides multispecies protection against Rift Valley fever
GM Warimwe, J Gesharisha, BV Carr, S Otieno, K Otingah, D Wright, ...
Scientific reports 6 (1), 20617, 2016
Haemoglobin C and S role in acquired immunity against Plasmodium falciparum malaria
F Verra, J Simpore, GM Warimwe, KK Tetteh, T Howard, FHA Osier, ...
PloS one 2 (10), e978, 2007
Systematic literature review of Rift Valley fever virus seroprevalence in livestock, wildlife and humans in Africa from 1968 to 2016
MHA Clark, GM Warimwe, A Di Nardo, NA Lyons, S Gubbins
PLoS neglected tropical diseases 12 (7), e0006627, 2018
Assessing the level and determinants of COVID-19 vaccine confidence in Kenya
S Orangi, J Pinchoff, D Mwanga, T Abuya, M Hamaluba, G Warimwe, ...
Vaccines 9 (8), 936, 2021
Protective efficacy of a novel simian adenovirus vaccine against lethal MERS-CoV challenge in a transgenic human DPP4 mouse model
VJ Munster, D Wells, T Lambe, D Wright, RJ Fischer, T Bushmaker, ...
npj Vaccines 2 (1), 28, 2017
Prognostic indicators of life-threatening malaria are associated with distinct parasite variant antigen profiles
GM Warimwe, G Fegan, JN Musyoki, CRJC Newton, M Opiyo, G Githinji, ...
Science translational medicine 4 (129), 129ra45-129ra45, 2012
The ratio of monocytes to lymphocytes in peripheral blood correlates with increased susceptibility to clinical malaria in Kenyan children
GM Warimwe, LM Murungi, G Kamuyu, GM Nyangweso, J Wambua, ...
PloS one 8 (2), e57320, 2013
Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley fever vaccine in mice
GM Warimwe, G Lorenzo, E Lopez-Gil, A Reyes-Sandoval, ...
Virology journal 10, 1-9, 2013
CLIMB-COVID: continuous integration supporting decentralised sequencing for SARS-CoV-2 genomic surveillance
SM Nicholls, R Poplawski, MJ Bull, A Underwood, M Chapman, ...
Genome biology 22, 1-21, 2021
COVID-19 transmission dynamics underlying epidemic waves in Kenya
SPC Brand, J Ojal, R Aziza, V Were, EA Okiro, IK Kombe, C Mburu, ...
Science 374 (6570), 989-994, 2021
A protective monoclonal antibody targets a site of vulnerability on the surface of Rift Valley fever virus
ER Allen, SA Krumm, J Raghwani, S Halldorsson, A Elliott, VA Graham, ...
Cell Reports 25 (13), 3750-3758. e4, 2018
The system can't perform the operation now. Try again later.
Articles 1–20